Avinger (NSDQ:AVGR) said late last week that it closed an approximately $11.5 million round of financing. In the offering, the Redwood City, Calif.-based company floated approximately 3.5 million Class A units at a price of 40¢ per share. Each unit offered consists of a single share of common stock and a five-year warrant to purchase […]
Avinger
Avinger registers for $17m offering
Avinger (NSDQ:AVGR) has registered for a new offering, looking to bring in approximately $17.3 million through the offering of various shares and warrants according to a recently posted SEC filing. The Redwood City, Calif.-based company said it will offer approximately 2.7 million Class A units consisting of a single share of common stock and a warrant […]
Avinger shareholders accept $5 million settlement
The plaintiffs in a class action suit against Avinger (NSDQ:AVGR) have approved the $5 million settlement that the company offered in March. Shareholders sued the company and several of its officers and directors claiming that they made false and misleading statements about Avinger’s original product, Pantheris, in its 2015 initial public offering. Avinger makes image-guided, catheter-based […]
Avinger asks for FDA approval of small-vessel PAD device
Avinger (NASDAQ:AVGR) has filed for 510(k) clearance of its Pantheris small-vessel “lumivascular” atherectomy device for treatment of peripheral artery disease (PAD). The Pantheris small vessel (SV) device extends the company’s line of Pantheris catheters, the first and only image-guided atherectomy devices for the treatment of PAD, which is estimated to affect over 12 million people in the […]
Avinger posts loss on disappointing sales
Avinger (NSDQ:AVGR) today posted a second-quarter losses-per-share that missed an analyst’s expectation, sending its share price down on Wall Street despite nearly halving its losses. The Redwood City, Calif.-based medical device maker reported losses of -$6.6 million, or -98¢ per share, on sales of $2.1 million for the three months ended June 30, 2018. That compares with […]
Avinger receives FDA approval for Pantheris altherectomy device
Avinger (Redwood City, Calif.) recently received FDA approval for its Pantheris image-guided altherectomy device that is designed to treat peripheral artery disease (PAD). Pantheris is the first medical device to be approved for diagnostics and treatment of PAD. The device lets doctors see inside arteries to treat blockages. It features a built-in camera and can […]
Avinger prices $4m offering
Avinger (NSDQ:AVGR) today priced an upcoming offering worth $3.6 million. The Redwood City, Calif.-based company said it is looking to float approximately 2.2 million shares of its common stock at $1.64 per share, hoping to bring in approximately $3.6 million. The offering will also include warrants for the purchase of half a share of common stock […]
Avinger launches next-gen Pantheris in US
Avinger (NSDQ:AVGR) said today it launched its next-generation Pantheris in the US, touting that the first procedures with the device have already been performed. Redwood City, Calif.-based Avinger said the newly launched Pantheris device features a single-balloon system designed both for apposition and blood flow occlusion and improved pushability and tissue storage capacity. The system is designed […]
Avinger launches post-market study comparing OCT to IVUS in PAD treatments
Avinger (NSDQ:AVGR) said today it launched a post-market study comparing optical coherence tomography to intravascular ultrasound as used during interventions in the peripheral arteries. The Redwood City, Calif.-based company’s Lumivascular tech, including its Pantheris image-guided atherectomy device and Ocelot image-guided chronic total occlusion crossing catheters, use OCT for real-time intravascular imaging during interventions to treat peripheral […]
Avinger wins FDA nod for next-gen Pantheris
Avinger (NSDQ:AVGR) said today it won FDA 510(k) clearance for its next-gen Pantheris lumivascular atherectomy system, which it touts as the first image-guided atherectomy device designed for treating peripheral artery disease. Redwood City, Calif.-based Avinger said the newly cleared Pantheris device features a simpler, single-balloon system designed both for apposition and blood flow occlusion and improved pushability […]
Update: Avinger shares rise on Q1 earnings
Updated to reflect corrected financial data from Avinger. Shares in Avinger (NSDQ:AVGR) rose today after the medical device maker posted first quarter earnings that saw losses shrinking, despite missing consensus on Wall Street. The Redwood City, Calif.-based company posted losses of $15.9 million, or $7.99 per share, on sales of $1.8 million for the three months […]